Adapalene

阿达帕林

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameAdapalene
Drug Alias Name6-[3-(1-金刚烷基)-4-甲氧基苯基]-2-萘甲酸adapalenumadapalenoDifferinDifferine +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor beta agonistsRetinoic acid receptor gamma agonists
TargetsRetinoic acid receptor betaRetinoic acid receptor gamma
Therapy Area/IndicationsPlantar WartSkin ManifestationsAcne Vulgaris +[4] 
Global Approved IndicationsAcne Vulgaris
Approved Indications in ChinaAcne Vulgaris
Original Approved Country/TerritoryEurope
Original Approved Date1992/01/01
Country/TerritoryBelizeCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGalderma Sa
China Registration ClassN/A

Develop Information

Active CompaniesIndonesian Medical Education and Research InstituteGalderma SaHeilongjiang Fuhe Huaxing Pharmaceutical Group Co Ltd
Inactive CompaniesGalderma R&DGalderma Laboratories LpUniversity Of Louisville +[8] 
Active IndicationsAcne Vulgaris
Inactive IndicationsPlantar WartSkin ManifestationsAcne Keloid

Other Information

ATC CodeD10AD03
Related LinksWikipediaDrugBankKEGG